Literature DB >> 12687415

Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex.

S Häussler1, C Lehmann, C Breselge, M Rohde, M Classen, B Tümmler, P Vandamme, I Steinmetz.   

Abstract

The aim of this study was to investigate the possible role of small-colony variant morphotypes of Burkholderia cepacia-like organisms in infectious complications in cystic fibrosis patients following lung transplantation. Respiratory tract specimens from 470 cystic fibrosis patients were screened over a 22-month period for Burkholderia cepacia-like organisms. Nineteen patients were positive for these organisms, eight of whom harboured small-colony-variant morphotypes. Three patients underwent bilateral lung transplantation during the study, two of whom harboured small-colony variants in addition to clonally identical wildtypes of Burkholderia multivorans and Burkholderia cepacia genomovar III prior to lung transplantation. Both patients developed fatal systemic infections post transplantation due to small-colony variants. In vitro testing revealed that small-colony variants exhibited increased serum resistance in comparison to wildtypes. The results of this study indicate that diagnostic efforts should be undertaken to carefully identify small-colony variants of Burkholderia cepacia complex, since they might be an indicator of poor post-transplantation outcome in patients with cystic fibrosis.

Entities:  

Mesh:

Year:  2003        PMID: 12687415     DOI: 10.1007/s10096-003-0901-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?

Authors:  J J LiPuma
Journal:  Transpl Infect Dis       Date:  2001-09       Impact factor: 2.228

2.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation.

Authors:  C Chaparro; J Maurer; C Gutierrez; M Krajden; C Chan; T Winton; S Keshavjee; M Scavuzzo; E Tullis; M Hutcheon; S Kesten
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

4.  Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  S Häussler; B Tümmler; H Weissbrodt; M Rohde; I Steinmetz
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

5.  Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures.

Authors:  H Anwar; M R Brown; P A Lambert
Journal:  J Gen Microbiol       Date:  1983-07

6.  Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

Authors:  R M Aris; J C Routh; J J LiPuma; D G Heath; P H Gilligan
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

7.  Burkholderia cepacia in cystic fibrosis. Variable disease course.

Authors:  D D Frangolias; E Mahenthiralingam; S Rae; J M Raboud; A G Davidson; R Wittmann; P G Wilcox
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

Review 8.  Four additional cases of Burkholderia gladioli infection with microbiological correlates and review.

Authors:  M Graves; T Robin; A M Chipman; J Wong; S Khashe; J M Janda
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

9.  Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.

Authors:  S L Butler; J W Nelson; I R Poxton; J R Govan
Journal:  FEMS Immunol Med Microbiol       Date:  1994-05

10.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

View more
  27 in total

1.  Ecological succession in long-term experimentally evolved biofilms produces synergistic communities.

Authors:  Steffen R Poltak; Vaughn S Cooper
Journal:  ISME J       Date:  2010-09-02       Impact factor: 10.302

2.  7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia.

Authors:  Magally Romero-Tabarez; Rolf Jansen; Marita Sylla; Heinrich Lünsdorf; Susanne Häussler; Dwi A Santosa; Kenneth N Timmis; Gabriella Molinari
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 3.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.

Authors:  Charles C Traverse; Leslie M Mayo-Smith; Steffen R Poltak; Vaughn S Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-27       Impact factor: 11.205

Review 5.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 6.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

7.  YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa.

Authors:  Jacob G Malone; Tina Jaeger; Christian Spangler; Daniel Ritz; Anne Spang; Cécile Arrieumerlou; Volkhard Kaever; Regine Landmann; Urs Jenal
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

Review 8.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

9.  Evaluation of the Merlin, Micronaut system for automated antimicrobial susceptibility testing of Pseudomonas aeruginosa and Burkholderia species isolated from cystic fibrosis patients.

Authors:  S Häussler; S Ziesing; G Rademacher; L Hoy; H Weissbrodt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-25       Impact factor: 3.267

10.  The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.

Authors:  Silke Besier; Johannes Zander; Barbara C Kahl; Peter Kraiczy; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.